DE3762341D1 - Chinolinderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. - Google Patents

Chinolinderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.

Info

Publication number
DE3762341D1
DE3762341D1 DE8787400165T DE3762341T DE3762341D1 DE 3762341 D1 DE3762341 D1 DE 3762341D1 DE 8787400165 T DE8787400165 T DE 8787400165T DE 3762341 T DE3762341 T DE 3762341T DE 3762341 D1 DE3762341 D1 DE 3762341D1
Authority
DE
Germany
Prior art keywords
carbon atoms
production
same
preparations containing
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787400165T
Other languages
English (en)
Inventor
Jean-Claude Vernieres
Jacques Simiand
Peter Eugene Keane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3762341D1 publication Critical patent/DE3762341D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8787400165T 1986-01-24 1987-01-23 Chinolinderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. Expired - Fee Related DE3762341D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8601401A FR2593810B1 (fr) 1986-01-24 1986-01-24 Derives de la quinoleine, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant

Publications (1)

Publication Number Publication Date
DE3762341D1 true DE3762341D1 (de) 1990-05-23

Family

ID=9331704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787400165T Expired - Fee Related DE3762341D1 (de) 1986-01-24 1987-01-23 Chinolinderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.

Country Status (14)

Country Link
US (1) US4835163A (de)
EP (1) EP0234995B1 (de)
JP (1) JPS62185074A (de)
AT (1) ATE52082T1 (de)
AU (1) AU587102B2 (de)
CA (1) CA1310324C (de)
DE (1) DE3762341D1 (de)
DK (1) DK35387A (de)
ES (1) ES2014479B3 (de)
FR (1) FR2593810B1 (de)
GR (1) GR3000440T3 (de)
NZ (1) NZ218918A (de)
PT (1) PT84172B (de)
ZA (1) ZA87348B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02157282A (ja) * 1988-12-12 1990-06-18 Wakunaga Pharmaceut Co Ltd 新規ピリドベンゾオキサジン誘導体
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
US6248736B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4412143Y1 (de) * 1966-09-28 1969-05-21
US3966743A (en) * 1968-07-23 1976-06-29 Boehringer Mannheim G.M.B.H. Ortho fused cycloalkano-4-quinolone-3-carboxylic acid derivatives
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4725306A (en) * 1984-11-09 1988-02-16 Daicel Chemical Industries Ltd. Pyridinecarboxamide plant growth inhibitors

Also Published As

Publication number Publication date
DK35387D0 (da) 1987-01-22
CA1310324C (en) 1992-11-17
AU6791687A (en) 1987-07-30
ZA87348B (en) 1987-08-26
ES2014479B3 (es) 1990-07-16
EP0234995A1 (de) 1987-09-02
ATE52082T1 (de) 1990-05-15
JPS62185074A (ja) 1987-08-13
PT84172B (pt) 1989-03-30
PT84172A (pt) 1987-02-01
FR2593810A1 (fr) 1987-08-07
AU587102B2 (en) 1989-08-03
US4835163A (en) 1989-05-30
FR2593810B1 (fr) 1988-04-22
EP0234995B1 (de) 1990-04-18
GR3000440T3 (en) 1991-06-28
NZ218918A (en) 1989-04-26
DK35387A (da) 1987-07-25

Similar Documents

Publication Publication Date Title
IL73893A (en) 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
TW274547B (de)
IL84537A0 (en) 1h-imidazo(4,5-c)quinolines and pharmaceutical compositions containing certain such compounds
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
IL57577A (en) 1,2-dihydroquinolin-2-one derivatives,processes for their preparation and pharmaceutical compositions containing the same
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
NZ231295A (en) Substituted alpha,omega-aminoalcohols and process for the preparation thereof
IL67812A (en) Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same
ATE97899T1 (de) 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
ATE15370T1 (de) 3-piperidinyl-indole derivate, ihre salze, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende arzneimittel.
DE3762341D1 (de) Chinolinderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
DE69005319T2 (de) 1,8-Benzonaphthyridinderivate und ihre Herstellung.
DE69125569D1 (de) 8-Azabicyclo[3.2.1]octylalkylthiazolidinone, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE70050T1 (de) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
DE3860117D1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE132867T1 (de) 20,21-dinoreburnaminderivate, substituiert in position 15, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende zusammensetzungen
ATE50992T1 (de) Verbrueckungsreagenz, verfahren zu seiner herstellung und seine anwendung.
ATE4384T1 (de) Benzothiopyrano(2,3-c)pyridine und ihre saeureadditions-salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
ATE28646T1 (de) Imidazo(1,2-a)chinoline, ihre salze, ihre herstellung und verwendung als arzneimittel und diese enthaltende zubereitungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee